- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Durect Corporation (DRRX)"Durect Corporation stock price live, this page displays NASDAQ DRRX stock exchange data. View the DRRX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Durect Corporation real time stock price chart below.
What Is the Durect Corporation Stock Price Today?
The Durect Corporation stock price today is 0.8700.
What Is the Stock Symbol for Durect Corporation?
The stock symbol for Durect Corporation is ""DRRX.""
What Stock Exchange Does Durect Corporation Trade On?
Durect Corporation is listed and trades on the NASDAQ stock exchange.
Is Durect Corporation a Good Stock to Buy?
Determining whether Durect Corporation—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DRRX quote. (ISIN: US2666055007)"
What Is the Durect Corporation Stock Price Today?
The Durect Corporation stock price today is 0.8700.
What Is the Stock Symbol for Durect Corporation?
The stock symbol for Durect Corporation is ""DRRX.""
What Stock Exchange Does Durect Corporation Trade On?
Durect Corporation is listed and trades on the NASDAQ stock exchange.
Is Durect Corporation a Good Stock to Buy?
Determining whether Durect Corporation—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DRRX quote. (ISIN: US2666055007)"
NASDAQ
Currency in USD
0.8700
-0.0500(-5.43%)
Real-time Data
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.8500
0.8846
52 wk Range
0.4810
1.8800
DRRX Scorecard
Full Analysis
2 analysts have revised their earnings upwards for the upcoming period
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.85000.8846
52 wk Range
0.48101.8800
Key Statistics
Edit
Book Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockDRRX Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Sell
Price Target
6.7500
Upside
+675.8621%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Durect Corporation Company Profile
DURECT Corporation, a biopharmaceutical company, develops medicines based on its epigenetic regulator program. The company’s lead product larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. It also offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. In addition, the company offers POSIMIR, a post-surgical pain product to deliver bupivacaine over three days in adults; and Methydur to treat attention deficit hyperactivity disorder. It markets and sells its ALZET lines through direct sales force in the United States, as well as through a network of distributors in other countries. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; and Innocoll Pharmaceuticals Limited. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino, California.
Compare DRRX to Peers and Sector
Metrics to compare | DRRX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipDRRXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.6x | −1.8x | −0.7x | |
PEG Ratio | −0.03 | −0.01 | 0.00 | |
Price/Book | 22.0x | 1.2x | 2.6x | |
Price / LTM Sales | 3.1x | 1.1x | 3.2x | |
Upside (Analyst Target) | - | 71.0% | 43.2% | |
Fair Value Upside | Unlock | 22.7% | 6.8% | Unlock |
Analysts' Recommendations
2 Buy
1 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 6.7500
(+675.86% Upside)
People Also Watch
FAQ
What Is the Durect (DRRX) Stock Price Today?
The Durect stock price today is 0.87
What Stock Exchange Does Durect Trade On?
Durect is listed and trades on the NASDAQ stock exchange.
What Is the Stock Symbol for Durect?
The stock symbol for Durect is "DRRX."
What Is the Durect Market Cap?
As of today, Durect market cap is 26.85M.
What is Durect Earnings Per Share?
The Durect EPS is -0.559.
From a Technical Analysis Perspective, Is DRRX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.